That first pulse of life, the careful, patterned movement of cells that creates a new organism, has always been something of a secret miracle. Now, MIT engineers have introduced a deep-learning model ...
Partnership aims to accelerate precision immunotherapy by leveraging AI-powered virtual cell models to identify which patients are most likely to benefit from BOT/BAL treatment Collaboration builds on ...
A generative AI system can now analyze blood cells with greater accuracy and confidence than human experts, detecting subtle signs of diseases like leukemia. It not only spots rare abnormalities but ...
For decades, the process of drug discovery has been a prolonged, costly, and unpredictable endeavor — an effort that ...
Somite, an AI-native TechBio company building the first universal virtual cell-signaling model, today announced its new identity, Cellular Intelligence. This rebrand reflects the company's vision to ...
The multi-modal approach leverages additional information from the patient's tumor sample, using Natera's AI models trained on long-term molecular and clinical outcomes from Natera's proprietary ...
insights from industryRafael E. Carazo SalasFounder and CEO CellVoyant In this interview, CellVoyant founder and CEO Rafael Carazo Salas explores how AI, live-cell imaging, and stem cell technologies ...
True ROI for R&D won't come from the tool that generates 10,000 new ideas. It will come from the tool that confidently tells ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback